D. Dietrich

1.5k total citations
21 papers, 980 citations indexed

About

D. Dietrich is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D. Dietrich has authored 21 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in D. Dietrich's work include Cancer Treatment and Pharmacology (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Bone health and treatments (2 papers). D. Dietrich is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Bone health and treatments (2 papers). D. Dietrich collaborates with scholars based in Switzerland, Germany and Poland. D. Dietrich's co-authors include Jürg Luterbacher, Elena Xoplaki, C. Schmutz, Christoph Beck, Heinz Wanner, R. Rickli, Dimitrios Gyalistras, Jucundus Jacobeit, H. Wanner and N. Steiner and has published in prestigious journals such as Journal of Clinical Oncology, Geophysical Research Letters and American Journal of Obstetrics and Gynecology.

In The Last Decade

D. Dietrich

20 papers receiving 928 citations

Peers

Countries citing papers authored by D. Dietrich

Since Specialization

Citations

This map shows the geographic impact of D. Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Dietrich more than expected).

Fields of papers citing papers by D. Dietrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Dietrich. The network helps show where D. Dietrich may publish in the future.

Co-authorship network of co-authors of D. Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of D. Dietrich. A scholar is included among the top collaborators of D. Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Dietrich. D. Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial 2023 ·European Journal of Cancer ·Antonia Digklia, Attila Kollár, D. Dietrich, (unknown), Christian Britschgi, Tamara Rordorf, Markus Joerger, Fatime Krasniqi, Yannis Metaxas, Ilaria Colombo, Karin Ribi, Christian Rothermundt	0
2	1867P Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents: A real-world cross-sectional study from Switzerland (SAKK 95/16) 2020 ·Annals of Oncology ·Karin Ribi, Beat Thuerlimann, (unknown), D. Dietrich, Richard Cathomas, (unknown), Thomas von Briel, Sandro Anchisi, Pierre Bohanes, (unknown), (unknown), Meinrad Mannhart, Clemens B. Caspar, Roger von Moos, Michael Mark	1
3	716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study 2020 ·Annals of Oncology ·Frank Stenner, Richard Cathomas, Christian Rothermundt, Julian Schardt, Anna Patrikidou, Deborah Zihler, Andreas Erdmann, (unknown), D. Dietrich, Catherine Berset, Gilles Godar, Dominik Berthold, Heinz Läubli	2
4	Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study (SAKK 95/16) 2019 ·Annals of Oncology ·Michael Mark, Beat Thuerlimann, Karin Ribi, (unknown), D. Dietrich, (unknown), Roger von Moos	1
5	Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma 2017 ·European Urology Supplements ·Jörg Ellinger, (unknown), (unknown), (unknown), (unknown), (unknown), Yuri Tolkach, D. Dietrich, G. Kristiansen, Susanne Müller	1
6	Dynamic posterior stabilization for degenerative lumbar spine disease: a large consecutive case series with long-term follow-up by additional postal survey 2016 ·European Spine Journal ·R. Greiner-Perth, (unknown), (unknown), D. Dietrich, Lukas Staub, Christoph Röder	9
7	Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06) 2015 ·Annals of Oncology ·Dieter Koeberle, Daniel Betticher, Roger von Moos, D. Dietrich, Peter Brauchli, (unknown), (unknown), Sun Young Rha, Markus Borner, Sandro Anchisi, Peter Moosmann, Attila Kollár, Piercarlo Saletti, A. Roth, M. Frueh, (unknown), Răzvan Popescu, (unknown), Viviane Hess, Richard Herrmann	92
8	Long-Term Outcome of Dasatinib First-Line Treatment in Gastrointestinal Stromal Tumors: a Multicenter Two Stage Phase Ii Trial Sakk 56/07 2014 ·Annals of Oncology ·Michael Montemurro, Angela Cioffi, Julien Dômont, Piotr Rutkowski, A. Roth, Roger von Moos, Roman Inauen, B. Bui, (unknown), (unknown), Sebastian Bauer, Philippe A. Cassier, (unknown), Axel Le Cesne, Dieter Koeberle, (unknown), D. Dietrich, Christine Biaggi, John O. Prior, Serge Leyvraz	3
9	Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? 2013 ·European Journal of Surgical Oncology ·Christoph Tausch, (unknown), D. Dietrich, (unknown), Heike Heuer, (unknown), (unknown)	46
10	Dasatinib First-Line Treatment in Gastrointestinal Stromal Tumors. a Multicenter Phase II Trial of the SAKK (SAKK 56/07) 2012 ·Annals of Oncology ·Michael Montemurro, Julien Dômont, Piotr Rutkowski, A. Roth, Roger von Moos, Roman Inauen, D. Dietrich, Christine Biaggi, John O. Prior, Serge Leyvraz	1
11	Benchmarking with Spine Tango: potentials and pitfalls 2009 ·European Spine Journal ·Christoph Röder, Lukas Staub, D. Dietrich, Thomas Zweig, Markus Melloh, Max Aebi	13
12	Avoiding misclassification bias with the traditional Charnley classification: Rationale for a fourth Charnley class BB 2006 ·Journal of Orthopaedic Research® ·Christoph Röder, Lukas Staub, Petra Eichler, Marcel Widmer, D. Dietrich, Stefan Eggli, Urs Müller	20
13	Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies 2006 ·British Journal of Cancer ·Serge Leyvraz, Richard Herrmann, L Guillou, Hanspeter Honegger, (unknown), Martin F. Fey, Cristiana Sessa, Martin Wernli, T. Cerny, D. Dietrich, Bernhard C. Pestalozzi	8
14	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 2006 ·Annals of Oncology ·Lucien Perey, Robert Paridaens, Hanne Hawle, Khalil Zaman, Franco Nolè, (unknown), Maryse Fiche, D. Dietrich, Patrice Clément, Dieter Köberle, Aron Goldhirsch, Beat Thürlimann	103
15	The impact of cetuximab on the capecitabine plus oxaliplatin (XELOX) combination in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK) 2006 ·Journal of Clinical Oncology ·Markus Borner, Walter Mingrone, Dieter Koeberle, Roger von Moos, Daniel Rauch, Piercarlo Saletti, R. Herrmann, D. Dietrich, Doris Lanz, A. Roth	25
16	European spring and autumn temperature variability and change of extremes over the last half millennium 2005 ·Geophysical Research Letters ·Elena Xoplaki, Jürg Luterbacher, Heiko Paeth, D. Dietrich, N. Steiner, Martín Grosjean, H. Wanner	253
17	Capecitabine in hormone-resistant metastatic prostatic carcinoma – a phase II trial 2004 ·British Journal of Cancer ·R. Morant, Jürg Bernhard, D. Dietrich, Silke Gillessen, M. Bonomo, Markus Borner, Jean Bauer, T. Cerny, Christoph Rochlitz, Martin Wernli, (unknown), Silvia Hanselmann, F. Hering, (unknown)	29
18	Reconstruction of sea level pressure fields over the Eastern North Atlantic and Europe back to 1500 2002 ·Climate Dynamics ·Jürg Luterbacher, Elena Xoplaki, D. Dietrich, R. Rickli, Jucundus Jacobeit, Christoph Beck, Dimitrios Gyalistras, C. Schmutz, Heinz Wanner	332
19	Minimum distance estimators in extreme value distributions 1996 ·Communication in Statistics- Theory and Methods ·D. Dietrich, J. Hüsler	7
20	Proliferative and malignant Brenner tumors 1981 ·American Journal of Obstetrics and Gynecology ·J. Donald Woodruff, D. Dietrich, Rene R. Genadry, T.H. Parmley	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact